Literature DB >> 21904504

Understanding the Mechanism of 5-ASA in Treating Colonic Inflammation.

Pierre Desreumaux1.   

Abstract

Entities:  

Year:  2008        PMID： 21904504      PMCID： PMC3093717     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.

Authors:  P Desreumaux; S Ghosh
Journal:  Aliment Pharmacol Ther       Date:  2006-09       Impact factor: 8.171

Review 2.  PPARgamma as a new therapeutic target in inflammatory bowel diseases.

Authors:  L Dubuquoy; C Rousseaux; X Thuru; L Peyrin-Biroulet; O Romano; P Chavatte; M Chamaillard; P Desreumaux
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

Review 3.  New pharmacological perspectives and therapeutic potential of PPAR-gamma agonists.

Authors:  C Alarcón de la Lastra; S Sánchez-Fidalgo; I Villegas; V Motilva
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

4.  Reduction of peroxisome proliferation-activated receptor gamma expression by gamma-irradiation as a mechanism contributing to inflammatory response in rat colon: modulation by the 5-aminosalicylic acid agonist.

Authors:  Christine Linard; Olivier Grémy; Marc Benderitter
Journal:  J Pharmacol Exp Ther       Date:  2007-12-12       Impact factor: 4.030

5.  Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma.

Authors:  Christel Rousseaux; Bruno Lefebvre; Laurent Dubuquoy; Philippe Lefebvre; Olivier Romano; Johan Auwerx; Daniel Metzger; Walter Wahli; Béatrice Desvergne; Gian Carlo Naccari; Philippe Chavatte; Amaury Farce; Philippe Bulois; Antoine Cortot; Jean Frédéric Colombel; Pierre Desreumaux
Journal:  J Exp Med       Date:  2005-04-11       Impact factor: 14.307
  5 in total
  2 in total

1.  Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis.

Authors:  Silvia Speca; Christel Rousseaux; Caroline Dubuquoy; Florian Rieder; Antonella Vetuschi; Roberta Sferra; Ilaria Giusti; Benjamin Bertin; Laurent Dubuquoy; Eugenio Gaudio; Pierre Desreumaux; Giovanni Latella
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

Review 2.  Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitis.

Authors:  Stephan Karl Böhm; Wolfgang Kruis
Journal:  Clin Exp Gastroenterol       Date:  2014-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.